HLA class I and II genotype of the NCI-60 cell lines
Open Access
- 4 March 2005
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 3 (1) , 11
Abstract
Sixty cancer cell lines have been extensively characterized and used by the National Cancer Institute's Developmental Therapeutics Program (NCI-60) since the early 90's as screening tools for anti-cancer drug development. An extensive database has been accumulated that could be used to select individual cells lines for specific experimental designs based on their global genetic and biological profile. However, information on the human leukocyte antigen (HLA) genotype of these cell lines is scant and mostly antiquated since it was derived from serological typing. We, therefore, re-typed the NCI-60 panel of cell lines by high-resolution sequence-based typing. This information may be used to: 1) identify and verify the identity of the same cell lines at various institutions; 2) check for possible contaminant cell lines in culture; 3) adopt individual cell lines for experiments in which knowledge of HLA molecule expression is relevant. Since genome-based typing does not guarantee actual surface protein expression, further characterization of relevant cell lines should be entertained to verify surface expression in experiments requiring correct antigen presentation.Keywords
This publication has 45 references indexed in Scilit:
- Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patientsInternational Journal of Cancer, 2004
- Mining our ABCsCancer Cell, 2004
- Web-Based Tools for Mining the NCI Databases for Anticancer Drug DiscoveryJournal of Chemical Information and Computer Sciences, 2003
- Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression dataThe Pharmacogenomics Journal, 2002
- The bioinformatics of microarray gene expression profilingCytometry, 2001
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Molecular targets in the National Cancer Institute drug screenJournal of Cancer Research and Clinical Oncology, 1995
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI: Journal of the National Cancer Institute, 1991